Trial Profile
A Phase III Trial Of ALIMTA Plus GEMZAR In Patients With Unresectable Or Metastatic Cancer Of The Pancreas
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2005
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 14 Oct 2005 New trial record.